Experiment 559086
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | CATIMEL,G: COQUARD,R: GUASTALLA,JP: MERROUCHE,Y: LE BAIL,N: ALAKL,MK: DUMORTIER,A: FOY,M: CLAVE,M:. (1995). PHASE 1 STUDY OF RP 49532A,A NEW PROTEIN-SYNTHESIS INHIBITOR,IN PATIENTS WITH ADVANCED REFRACTORY SOLID TUMORS.. 35(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | THIS IS A PHASE 1 STUDY INVOLVING 12 PATIENTS WITHADVANCED REFRACTORY SOLID TUMOURS.DOSE LIMITING TOXIC EFFECTS WERE HYPOTENSION AND ASTHENIA. |
| Dose amount | 15.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |
| Gender | MALE |